{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:21:52Z","timestamp":1778595712300,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H29-shinkougyousei-shitei-005"],"award-info":[{"award-number":["H29-shinkougyousei-shitei-005"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jiac.2019.08.013","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T17:08:06Z","timestamp":1568912886000},"page":"211-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Relationship between drug formulary and frequently used cephalosporins, macrolides and quinolones in Japanese hospitals"],"prefix":"10.1016","volume":"26","author":[{"given":"Yoshiki","family":"Kusama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Muraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanako","family":"Kurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.08.013_bib1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","article-title":"Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis","volume":"17","author":"Baur","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2019.08.013_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2042098614554919","article-title":"Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem","volume":"5","author":"Llor","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jiac.2019.08.013_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jgar.2016.07.002","article-title":"Japanese antimicrobial consumption surveillance: first report on oral and parenteral antimicrobial consumption in Japan (2009-2013)","volume":"7","author":"Muraki","year":"2016","journal-title":"J\u00a0Glob Antimicrob Resist"},{"key":"10.1016\/j.jiac.2019.08.013_bib4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jiac.2018.01.003","article-title":"Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016","volume":"24","author":"Tsutsui","year":"2018","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.08.013_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s15010-017-1097-x","article-title":"The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011\u20132013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group","volume":"46","author":"Yamasaki","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2019.08.013_bib6","series-title":"ATC\/DDD index","year":"2018"},{"key":"10.1016\/j.jiac.2019.08.013_bib7","series-title":"The selection and use of essential medicines","year":"2017"},{"key":"10.1016\/j.jiac.2019.08.013_bib8","series-title":"National action plan on antimicrobial resistance (AMR) 2016-2020","year":"2016"},{"key":"10.1016\/j.jiac.2019.08.013_bib9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/AAC.14.2.172","article-title":"Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function","volume":"14","author":"Spyker","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.08.013_bib10","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1185\/030079906X148355","article-title":"Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults","volume":"22","author":"Giordano","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jiac.2019.08.013_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/AAC.41.4.739","article-title":"Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study Group","volume":"41","author":"Tack","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.08.013_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0149-2918(98)80088-X","article-title":"Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The cefdinir adult skin infection study group","volume":"20","author":"Tack","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiac.2019.08.013_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0033-3506(97)00581-7","article-title":"Risk factors for methicillin-resistant staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital","volume":"111","author":"Washio","year":"1997","journal-title":"Public Health"},{"key":"10.1016\/j.jiac.2019.08.013_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jpubeco.2010.03.006","article-title":"Choice proliferation, simplicity seeking, and asset\u00a0allocation","volume":"94","author":"Iyengar","year":"2010","journal-title":"J\u00a0Public Econ"},{"key":"10.1016\/j.jiac.2019.08.013_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/B:BUSI.0000035906.74034.d4","article-title":"Choose, choose, choose, choose, choose, choose, choose: emerging and prospective research on the deleterious effects of living in consumer hyperchoice","volume":"52","author":"Mick","year":"2004","journal-title":"J\u00a0Bus Ethics"},{"key":"10.1016\/j.jiac.2019.08.013_bib16","series-title":"Surveillance of antimicrobial use based on\u00a0National Database","year":"2018"},{"key":"10.1016\/j.jiac.2019.08.013_bib17","doi-asserted-by":"crossref","first-page":"A816","DOI":"10.1016\/j.jval.2016.08.670","article-title":"Development of hospital formulary in Japan - current trends and issues","volume":"19","author":"Hamashima","year":"2016","journal-title":"Value Health"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2019.08.013_bib18","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1093\/ofid\/ofx163.578","article-title":"Formulary management and antimicrobial stewardship: a 7-year evaluation at an integrated health-system","volume":"4","author":"Veve","year":"2017","journal-title":"Open Forum Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:55:21Z","timestamp":1778594121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18303507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1341321X18303507"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.08.013","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between drug formulary and frequently used cephalosporins, macrolides and quinolones in Japanese hospitals","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}